2013 | Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy | LIVER INTERNATIONAL |
2012 | Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2013 | Early Predictor of Mortality due to Irreversible Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma | WORLD JOURNAL OF SURGERY |
2011 | Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma | LIVER INTERNATIONAL |
2017 | Effect of S267F variant of NTCP on the patients with chronic hepatitis B
| SCIENTIFIC REPORTS |
2021 | Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
2020 | Effect of urea cream on sorafenib-associated hand-foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study | EUROPEAN JOURNAL OF CANCER |
2017 | Effect of yttrium-90 radioembolization on outcomes in Asian patients with early to advanced stage hepatocellular carcinoma | HEPATOLOGY RESEARCH |
2014 | Effective Biliary Drainage and Proper Treatment Improve Outcomes of Hepatocellular Carcinoma with Obstructive Jaundice
| GUT AND LIVER |
2020 | Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study
| NUTRIENTS |
2017 | Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study
| MEDICINE |
2017 | Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
| GUT AND LIVER |
2022 | Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT |
2010 | Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines
| Korean Journal of Hepatology (대한간학회지) |
2020 | Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma | HEPATOLOGY INTERNATIONAL |
2021 | Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
| CLINICAL AND MOLECULAR HEPATOLOGY |
2020 | Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2015 | Efficacy and safety of pegylated interferon base treatment in patients with chronic hepatitis C on dialysis | EUROPEAN JOURNAL OF INTERNAL MEDICINE |
2009 | Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
2010 | Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B. | JOURNAL OF MEDICAL VIROLOGY |
2015 | Efficacy of perifosine alone and in combination with sorafenib in an HrasG12V plus shp53 transgenic mouse model of hepatocellular carcinoma | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2013 | Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
| PLOS ONE |
2013 | Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir
| WORLD JOURNAL OF GASTROENTEROLOGY |
2018 | Elbasvir/Grazoprevir in Asia-Pacific/Russian Participants With Chronic Hepatitis C Virus Genotype 1 ,4 ,or 6 Infection
| HEPATOLOGY COMMUNICATIONS |
2016 | Elucidation of Relevant Neuroinflammation Mechanisms Using Gene Expression Profiling in Patients with Amyotrophic Lateral Sclerosis
| PLOS ONE |
2014 | Emerging therapies for hepatitis C
| GUT AND LIVER |
2020 | Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma | JOURNAL OF VIRAL HEPATITIS |
2021 | Epidemiological and Clinical History of Viral Hepatitis in Korea
| INFECTION AND CHEMOTHERAPY |
2022 | Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2020 | Establishment and Validation of a Risk Prediction Model in Patients With Hepatocellular Carcinoma Treated With Transarterial Radioembolization | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2017 | Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea
| PLOS ONE |
2016 | Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea
| MEDICINE |
2017 | Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy
| GUT AND LIVER |
2019 | Evaluation of Early Response to Treatment of Hepatocellular Carcinoma with Yttrium-90 Radioembolization Using Quantitative Computed Tomography Analysis
| KOREAN JOURNAL OF RADIOLOGY |
2021 | Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years | JOURNAL OF DIABETES AND ITS COMPLICATIONS |
2022 | Expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma
| JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals | JOURNAL OF VIRAL HEPATITIS |
2010 | External validation of P2/MS and comparison with other simple non-invasive indices for predicting liver fibrosis in HBV-infected patients | DIGESTIVE DISEASES AND SCIENCES |
2022 | External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
| CANCERS |
2019 | External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy | LIVER INTERNATIONAL |
2020 | Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2014 | Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
| PLOS ONE |
2015 | Factors associated with significant liver fibrosis assessed using transient elastography in general population
| WORLD JOURNAL OF GASTROENTEROLOGY |
2016 | Factors Influencing the Diagnostic Accuracy of Acoustic Radiation Force Impulse Elastography in Patients with Chronic Hepatitis B
| GUT AND LIVER |
2019 | Failure of hepatocellular carcinoma surveillance: inadequate echogenic window and macronodular parenchyma as potential culprits
| ULTRASONOGRAPHY |
2019 | Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
| BMC CANCER |
2018 | Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B | LIVER INTERNATIONAL |
2020 | Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study | MODERN RHEUMATOLOGY |
2019 | Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers | LIVER INTERNATIONAL |
2022 | Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
| GUT AND LIVER |
2017 | Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2011 | Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2020 | Genetically Engineered Mouse Models for Liver Cancer
| CANCERS |
2022 | Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study | LANCET GASTROENTEROLOGY & HEPATOLOGY |
2018 | HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study | RHEUMATOLOGY INTERNATIONAL |
2018 | HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma
| CANCER RESEARCH AND TREATMENT |
2017 | Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study | ACTA RADIOLOGICA |
2021 | Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2016 | Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model | JOURNAL OF HEPATOLOGY |
2015 | Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |